Shanghai RAAS Blood Products Investor Relations Material
Latest events
Q1 2025
28 Apr, 2025
Q4 2024
17 Apr, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Shanghai RAAS Blood Products Co Ltd
Access all reports
Shanghai RAAS Blood Products Co., Ltd. is a Chinese healthcare company focused on the research, development, production, and distribution of plasma-derived biopharmaceutical products. The company produces a variety of blood plasma-based therapies, including immunoglobulins, albumin, and coagulation factor products, used in the treatment of immune deficiencies, blood disorders, and other medical conditions. The company is headquartered in Shanghai, China, and its shares are listed on the Shenzhen Stock Exchange.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
002252
Country
🇨🇳 China